Malignant Neoplasm of Stomach Completed Phase 3 Trials for Cisplatin (DB00515)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00296335Trial of Adjuvant Chemotherapy for Gastric CancerTreatment
NCT00296322Trial of Adjuvant Chemotherapy for Gastric CancerTreatment
NCT01824459S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma PatientsTreatment
NCT00052910Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal CancerTreatment
NCT00002615Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach CancerTreatment
NCT00020787Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal CancerTreatment
NCT00123318A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric CancerTreatment
NCT00142350A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric CancerTreatment
NCT00150670Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric CancerTreatment
NCT00182611S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach CancerTreatment
NCT00323830Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric AdenocarcinomaTreatment
NCT00400179A Safety and Efficacy Study in Patients With Gastric CancerTreatment
NCT00678535Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric CancerTreatment
NCT00887822A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Cisplatin as First-Line Therapy for Advanced Gastric CancerTreatment
NCT01041404ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric CancerTreatment
NCT01671449S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric CancerTreatment
NCT02563054A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric CancerTreatment